FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093136 [Registered on: 18/08/2025] Trial Registered Prospectively
Last Modified On: 14/08/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Efficacy of urinary tract infection prevention device in patients with urinary catheter 
Scientific Title of Study   Efficacy of the catheter associated urinary tract infections (CAUTI) prevention device - UTINIL in patients with indwelling urinary catheter: A randomized controlled double blind study 
Trial Acronym  NIL-UTI 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Premangshu Ghoshal 
Designation  Senior Resident (Academic) 
Affiliation  All India Institute Of Medical Sciences, New Delhi 
Address  Room 5011, 5th Floor, Academic Building, Department office, Anaesthesiology, Pain Medicine and Critical Care, AIIMS New Delhi - 110029

New Delhi
DELHI
110029
India 
Phone  7003664307  
Fax    
Email  premangshu.ghoshal400@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shailendra Kumar 
Designation  Additional Professor 
Affiliation  All India Institute Of Medical Sciences, New Delhi 
Address  Room Number 4, Porta Cabin, 5th Floor, Academic Building, Department of Anaesthesiology, Pain Medicine and Critical Care, AIIMS New Delhi - 110029

New Delhi
DELHI
110029
India 
Phone  8984354307  
Fax    
Email  drshail.kumar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shailendra Kumar 
Designation  Additional Professor 
Affiliation  All India Institute Of Medical Sciences, New Delhi 
Address  Room Number 4, Porta Cabin, 5th Floor, Academic Building, Department of Anaesthesiology, Pain Medicine and Critical Care, AIIMS New Delhi - 110029

New Delhi
DELHI
110029
India 
Phone  8984354307  
Fax    
Email  drshail.kumar@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Medical Sciences, New Delhi Address: Ansari Nagar, New Delhi - 110029, Country - India 
 
Primary Sponsor  
Name  Dr Premangshu Ghoshal 
Address  Room Number 5011, 5th Floor, Academic Building, Department Office, Department of Anaesthesiology, Pain Medicine and Critical Care, AIIMS New Delhi, Ansari Nagar, New Delhi 110029, Country - India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Shailendra Kumar  Porta Cabin, 5th Floor, Academic Building, AIIMS New Delhi 110029 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Premangshu Ghoshal  All India Institute Of Medical Sciences, New Delhi  BPS5 ICU, 5th Floor, Burn and Plastic Surgery Building, AIIMS New Delhi 110029 and AB8 ICU, 8th floor, Ward block, AIIMS New Delhi and SBICU, Surgical Block, AIIMS New Delhi and Room Number 5011, 5th Floor, Academic Building, Department office, Department of Anaesthesiology, Pain Medicine and Critical Care, AIIMS New Delhi 110029
New Delhi
DELHI 
7003664307

premangshu.ghoshal400@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee For Post Graduate Research, All India Institute Of Medical Sciences, Ansari Nagar, New Delhi 110029  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N390||Urinary tract infection, site notspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Device off  Device attached for 10 days to silicone urinary catheter 3 cm distal to urethral opening after 48 hours of catheterisation with device turned off 
Intervention  Device On  Device attached for 10 days to silicone urinary catheter 3 cm distal to urethral opening after 48 hours of catheterisation with device turned on 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Adult patients of more than 18 years age being admitted to ICU requiring Foleys catheterization 
 
ExclusionCriteria 
Details  1. Active UTI or history of UTI or Culture proven UTI within past 14 days
2. History of urological surgery or trauma
3. History of renal pathology
4. Expected discharge or survival in ICU less than 48 hours
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Urinary bacterial colony count during catheter indwelling period between two groups  At Day 10 of catheterisation 
 
Secondary Outcome  
Outcome  TimePoints 
Incidence of UTI (cases /1000 catheter days) in catheterized ICU patients with and without the device  Within 10 days of catheterisation 
Incidence of asymptomatic bacteriuria and candiduria   Within 10 days of catheterisation 
Incidence of catheter blockage  Within 10 days of catheterisation 
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Catheter Associated Urinary Tract Infections [CAUTI] is one of the most common hospital acquired infections. Each day the indwelling catheter remains, risk of acquiring CAUTI increases by 3-7% as per CDC Reference of January 2024. The consequences of untreated CAUTI associated with excess morbidity, mortality, antimicrobial agent use and health care costs. This new device used in our study is a novel add-on device which focuses on both extraluminal and intraluminal routes of infections. It might be effective in prevent both endogenous and exogenous bacteria ascending to the urinary bladder.  The device irradiates UV light which might be effective in disinfecting the bacteria and also releases low-frequency vibration/ surface acoustic waves (SAW) which may have potential to prevent biofilm formation and bacterial colonization on the catheter surface. It will not increase the antimicrobial resistance burden. There is currently no evidence available which shows that combining UV light to surface acoustic wave via a single device can confer better prevention from UTI than standard catheter care. This study aims to find the combined effect of these two modalities in prevention of CAUTI.

 
Close